1. Home
  2. HARP

HARP

Harpoon Therapeutics Inc.

Logo Harpoon Therapeutics Inc.

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

0

Harpoon Therapeutics Inc is a clinical-stage immunotherapy company. It is engaged in developing a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases. The company's pipeline products include HPN424, HPN536, HPN217, and others.

Founded: 2015 Country:
United States
United States
Employees: N/A City: SOUTH SAN FRANCISCO
Market Cap: 491.9M IPO Year: 2019
Target Price: $27.25 AVG Volume (30 days): 1.2M
Analyst Decision: Buy Number of Analysts: 5
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -8.76 EPS Growth: N/A
52 Week Low/High: $3.11 - $23.21 Next Earning Date: 03-25-2024
Revenue: $37,341,000 Revenue Growth: 16.14%
Revenue Growth (this year): 21.61% Revenue Growth (next year): -45.69%

Share on Social Networks: